Effects of Nopal Fractions on Postprandial Glucose Regulation and Appetite Variables in Healthy Humans

NCT ID: NCT04439630

Last Updated: 2020-10-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-01

Study Completion Date

2020-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postprandial effects of Nopal fractions on glucose and appetite regulation will be investigated in healthy humans, in a randomised controlled crossover trial

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glucose Tolerance Appetite Sensations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

randomised crossover study in healthy young adults with normal BMI
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants
Participants knew which test products that were included in the study, but not the consumption order

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

reference

Test product without the active components

Group Type SHAM_COMPARATOR

Test product without the active components

Intervention Type DIETARY_SUPPLEMENT

Test product without the active components

Nopal fraction 1

Fraction one out of two possible

Group Type EXPERIMENTAL

Nopal fractions

Intervention Type DIETARY_SUPPLEMENT

Nopal flour were divided in two fractions and mixed in two different test breads

Nopal fraction 2

Fraction two out of two possible

Group Type EXPERIMENTAL

Nopal fractions

Intervention Type DIETARY_SUPPLEMENT

Nopal flour were divided in two fractions and mixed in two different test breads

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nopal fractions

Nopal flour were divided in two fractions and mixed in two different test breads

Intervention Type DIETARY_SUPPLEMENT

Test product without the active components

Test product without the active components

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy
* non-smokers
* diet accordance with the Nordic Nutrition Recommendations
* BMI: 18.5-25 kg/m2

Exclusion Criteria

* metabolic disorders
* food allergies
* no probiotics or other food /supplement which may interfere with the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Lund University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anne Nilsson

Associate professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anne Nilsson, assoc. prof.

Role: PRINCIPAL_INVESTIGATOR

Lund University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Food Technology, engineering and Nutrition, LTH, Lund University

Lund, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Protokoll 2018/8-b

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Antidiabetic Properties of Rose Hip
NCT01316016 COMPLETED NA
Palm And Rice Bran Oil Study
NCT02969057 COMPLETED NA